The Global Isoflavones Market size is expected to reach $1.4 billion by 2027, rising at a market growth of 6.4% CAGR during the forecast period. Isoflavones refer to the polyphenolic compounds that show estrogen-antagonist and estrogen-agonist characteristics. Glycitein, genistein, and daidzein are the most active isoflavones available in soybeans and that are also the phytoestrogens with robust estrogenic activity. Various clinical studies have shown that genistein and daidzein are extremely helpful to prevent prostate and breast cancer, osteoporosis, and cardiovascular diseases and provide relief in postmenopausal symptoms.
The isoflavones market would witness lucrative growth opportunities due to the rise in awareness about the health advantages of isoflavones along with the growing geriatric population. Moreover, the global market is expected to be fueled by the rising number of working women and an increase in the purchasing power of consumers for healthy food products.
Furthermore, the growth of the market would be augmented by the increasing demand for nutraceutical supplements across every age group along with the rising disposable income of the global population. Geriatrics has been the global trend in well-established as well emerging countries. Consumers around the world are getting concerned about the changes in their quality of life and are closely monitoring their food habits. The consumption of infant formula having flavonoids has been fueled due to the growing number of working mothers around the globe, thereby boosting the demand & growth of the isoflavones in the market.
The outbreak of the COVID-19 pandemic has had a significant impact on the isoflavones market. Isoflavones find wide-range applications in various products such as nutraceuticals, dietary supplements, and pharmaceuticals. Isoflavones-based products are beneficial in enhancing muscle mass and immunity. Due to this aspect, the demand for isoflavones products has been increased in the last couple of years.
The demand for isoflavones among consumers has been fueled due to the increase in health concerns and higher consumer awareness, hence leading to the huge demand for fortified foods. Along with the available medical health supplements, consumers are highly inclined towards isoflavones dietary supplements as they are made from plants. The awareness of the consumers regarding the consumption of a healthy diet and supplements has been boosted due to the outbreak of the COVID-19 pandemic. Most of the dietary supplements and nutraceuticals products comprise isoflavones that are helpful in boosting gut health. Therefore, the outbreak of the COVID-19 pandemic has significantly affected the growth of the isoflavones market.
Women at the menopause phase face different kinds of problems like insomnia, hot flashes, and in many instances, sexual dysfunction. Most of the women are tend to purchase supplements that have estrogen that could substantially increase the possibility of blood clots, breast, stroke, or uterine cancer. Therefore, estrogen is not the feasible choice for most of women due to their health and family health history.
The utilization of nanotechnology for the synthesis of APIs is one of the new improvements in drug developments. The advent of nanoparticle technologies for the delivery of APIs effectively displays its high potential as an innovative and effective approach. Nanobodies are the same as single-domain antibodies that can be fixed to particular antigens; though, they are lesser in size in comparison to antibodies.
Soy isoflavones can take various weeks or more to reach their market advantages. For instance, according to Healthline Media (US), a 2015 study revealed that soy isoflavones take above 13 weeks to reach just half of their highest effect. Conventional hormones like estrogen therapy; however, take approximately three weeks to display the same kinds of advantages.
Based on Form, the market is segmented into Powder and liquid. The powder segment procured the maximum revenue share of the global isoflavones market in 2020. This is due to trends prevailing in the isoflavones market like easy handling and usage of isoflavones in various nutraceutical and pharmaceutical applications.
Based on Application, the market is segmented into Pharmaceuticals, Nutraceuticals, Cosmetics and Food & Beverages. The pharmaceuticals segment would acquire the maximum revenue share throughout the forecasting period. This is due to the increasing application of isoflavones because of their therapeutic and functional properties.
Based on Source, the market is segmented into Red Clover, Soy and Other Sources. Isoflavones are extracted from peas, soybeans, red clover, and other natural sources. Soy-based extracts obtained the highest revenue share of the global market in 2020. Moreover, the segment is likely to exhibit a similar kind of trend during the forecast period. Other sources like lentils, red clover, peas, beans, green tea, and flaxseeds acquired a moderate revenue share of the global isoflavones market in 2020. Numerous research organizations that do the extraction process are striving to create the latest and advanced methods for extracting the isoflavones from their sources.
| Report Attribute | Details |
|---|---|
| Market size value in 2020 | USD 842.4 Million |
| Market size forecast in 2027 | USD 1.4 Billion |
| Base Year | 2020 |
| Historical Period | 2017 to 2019 |
| Forecast Period | 2021 to 2027 |
| Revenue Growth Rate | CAGR of 6.4% from 2021 to 2027 |
| Number of Pages | 181 |
| Number of Tables | 350 |
| Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling |
| Segments covered | Form, Application, Source, Region |
| Country scope | US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria |
| Growth Drivers |
|
| Restraints |
|
Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. Asia-Pacific is one of the leading regions of the global isoflavones market. Some of the major countries of the region are India, China, Japan, and South Korea that are also the biggest consumers of soy and its products in the world. As a result, the demand for isoflavones is not very high in such countries. The demand for the product in Asian economies is quite less in comparison to the western countries due to the high consumption of beans, soy, peas, and other sources in their daily diet. Moreover, a significant portion of the population is suffering from breast cancer and other diseases, hence bolstering the demand of isoflavones in the regional market.
Free Valuable Insights: Global Isoflavones Market size to reach USD 1.4 Billion by 2027
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Archer Daniels Midland Company, BASF SE, Koninklijke DSM N.V., International Flavors & Fragrances, Inc. (DuPont Nutrition), Shanghai Freemen, LLC, Nexira, Inc., Hyundai Bioland, Tradichem S.L., FutureCeuticals, Inc. (R. J. Van Drunen & Sons, Inc.), and Lactonova Nutripharm Pvt. Ltd.
By Form
By Application
By Source
By Geography
The isoflavones market size is projected to reach USD 1.4 billion by 2027.
Increasing demand for ready-to-eat and packaged food are driving the market in coming years, however, Surging prices of raw materials used in the preparation of isoflavones have limited the growth of the market.
Archer Daniels Midland Company, BASF SE, Koninklijke DSM N.V., International Flavors & Fragrances, Inc. (DuPont Nutrition), Shanghai Freemen, LLC, Nexira, Inc., Hyundai Bioland, Tradichem S.L., FutureCeuticals, Inc. (R. J. Van Drunen & Sons, Inc.), and Lactonova Nutripharm Pvt. Ltd.
During the pandemic, the sales of isoflavones were gradually increased and it is likely to increase rapidly in the coming years. This is attributed to the rising urbanization, growing demand for western-style diets, and increasing disposable incomes.
The soy segment obtained the maximum revenue share of the global isoflavones market in 2020.
The North America market dominated the Global isoflavones Market by Region 2020, growing at a CAGR of 17.9 % during the forecast period. The Europe market is experiencing a CAGR of 18.8% during (2021 - 2027).
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
